| For: | Gao YX, Ning QQ, Yang PX, Guan YY, Liu PX, Liu ML, Qiao LX, Guo XH, Yang TW, Chen DX. Recent advances in recurrent hepatocellular carcinoma therapy. World J Hepatol 2023; 15(4): 460-476 [PMID: 37206651 DOI: 10.4254/wjh.v15.i4.460] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5204/full/v15/i4/460.htm |
| Number | Citing Articles |
| 1 |
Zhengguang Zhang, Yuanchao Feng, Ziming Mu, Wenjia Zhang, Fuqiong Zhou. Huaier counteracts sorafenib resistance in hepatocellular carcinoma by activating NCOA4-mediated ferritinophagy to induce ferroptosis via modulation of iron and lipid metabolism. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2026; 1872(7) doi: 10.1016/j.bbadis.2026.168313
|
| 2 |
Noura A A Ebrahim, Thoraya A Farghaly, Ahmed Abdo El-Sherif, Ahmed M Fahmy, Moamen O Othman, Neveen S Tahoun, Omnia Mohamed Korany, Aya Arafat, Reham Oreaba, Soliman M A Soliman. Clinicopathological insights and management of liver metastases: Current advances and future perspectives. World Journal of Hepatology 2025; 17(10): 110026 doi: 10.4254/wjh.v17.i10.110026
|
| 3 |
Shivani Desai, Katrina A. McGinty, Andrew Canakis, Lee-Ching Zhu, Neil D. Shah. Leave No “Stone” Unturned: Biliary Obstruction From Isolated Intraductal Metastatic HCC. ACG Case Reports Journal 2025; 12(7) doi: 10.14309/crj.0000000000001766
|
| 4 |
Abhimati Ravikulan, Kamran Rostami. Leveraging machine learning for early recurrence prediction in hepatocellular carcinoma: A step towards precision medicine. World Journal of Gastroenterology 2024; 30(5): 424-428 doi: 10.3748/wjg.v30.i5.424
Abstract(864) |
Core Tip(873) |
Full Article(HTML)(3206)
|
Full Article (PDF)-550K(262)
|
Full Article with Cover (PDF)-3548K(265)
|
Full Article (Word)-242K(30)
|
Full Article (XML)-38K(187)
|
Audio-234K(28)
|
Peer-Review Report-224K(194)
|
Answering Reviewers-264K(165)
|
Times Cited (10)
|
Total Visits (5057)
|
Open
|
| 5 |
Zijie Wu, Zehua Dong, Jiangti Luo, Weiwei Hu, Yue Tong, Xiangdong Gao, Wenbing Yao, Hong Tian, Xiaosheng Wang. A comprehensive comparison of molecular and phenotypic profiles between hepatitis B virus (HBV)-infected and non-HBV-infected hepatocellular carcinoma by multi-omics analysis. Genomics 2024; 116(3) doi: 10.1016/j.ygeno.2024.110831
|
| 6 |
Guangce Xia, Yulin Guo, Jiajia Zhang, Meng Han, Xiangchao Meng, Ji Lv. An Overview of the Deubiquitinase USP53: A Promising Diagnostic
Marker and Therapeutic Target. Current Protein & Peptide Science 2024; 25(9) doi: 10.2174/0113892037292440240518194922
|
| 7 |
Gregor Jazbec, Tadeja Režen. Circular RNA in hepatocellular carcinoma: emerging therapeutic strategies. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1722576
|
| 8 |
Lu Zheng, Xiao-Bing Huang, Chong-Yu Zhao, Wang Xi, Jing Li, Zheng Wang, Yong-Gang He. Pathologic complete response to conversion therapy in hepatocellular carcinoma using patient-derived organoids: A case report. World Journal of Gastrointestinal Oncology 2024; 16(11): 4506-4513 doi: 10.4251/wjgo.v16.i11.4506
|
| 9 |
Zewei Zhuo, Huihuan Wu, Lingli Xu, Yuran Ji, Jiezhuang Li, Liehui Liu, Hong Zhang, Qi Yang, Zhongwen Zheng, Weijian Lun. Machine learning-based integration reveals immunological heterogeneity and the clinical potential of T cell receptor (TCR) gene pattern in hepatocellular carcinoma. Apoptosis 2025; 30(3-4) doi: 10.1007/s10495-025-02080-6
|
| 10 |
Hema Shree K, Gayathri R, Vishnu Priya Veeraraghavan, Selvaraj J, Pratibha Ramani. Pro-inflammatory mediator and cancer-associated chemokine CXCL8 as a prognostic indicator of tumor aggressiveness, angiogenesis, and disease progression with focus on therapeutic implications and recurrence monitoring. Oral Oncology Reports 2025; 13 doi: 10.1016/j.oor.2025.100723
|
| 11 |
Abdullah Alshamrani, Sung Ki Cho, Namkee Oh, Jinsoo Rhu, Gyu-Seong Choi, Dong-Ho Hyun, Jongman Kim. The Role of TARE for Bridging and Downstaging of HCC Before Resection or Liver Transplant. Cancers 2026; 18(2) doi: 10.3390/cancers18020225
|
| 12 |
Xuan-Yu Gu, Zheng-Jun Zhou, Hua Yao, Jia-Li Yang, Jin Gu, Rui Mu, Li-Jin Zhao. The role of transketolase in the immunotherapy and prognosis of hepatocellular carcinoma: a multi-omics approach. Frontiers in Immunology 2025; 16 doi: 10.3389/fimmu.2025.1529029
|
| 13 |
Cheng Lin, Yue Wan, Qiang Huo, Dachuan Liu, Xinhua Liu, Hao Liu, Yixuan Zhang, Xiu Cheng. Chemoproteomics reveals Ailanthone directly binds to PKM2 to inhibit the progression of Hepatocellular carcinoma. Phytomedicine 2025; 143 doi: 10.1016/j.phymed.2025.156886
|
| 14 |
Lien-Hung Huang, Shao-Chun Wu, Yueh-Wei Liu, Hang-Tsung Liu, Peng-Chen Chien, Hui-Ping Lin, Chia-Jung Wu, Ting-Min Hsieh, Ching-Hua Hsieh. Identification of Crucial Cancer Stem Cell Genes Linked to Immune Cell Infiltration and Survival in Hepatocellular Carcinoma. International Journal of Molecular Sciences 2024; 25(22) doi: 10.3390/ijms252211969
|
| 15 |
Mohamed Wishahi. Erdafitinib and checkpoint inhibitors for first-line and second-line immunotherapy of hepatic, gastrointestinal, and urinary bladder carcinomas: Recent concept. World Journal of Hepatology 2024; 16(4): 490-493 doi: 10.4254/wjh.v16.i4.490
|
| 16 |
Zijie Zheng, Yuening Wang, Wenyue Zhang, Guoqing Du, Baoming Luo. Machine Learning-Based Sialylation-Associated Gene Signature Predicts Prognosis and Immune Landscape in Hepatocellular Carcinoma: Validation via Multi-Omics Analysis and in vitro Assays. Journal of Hepatocellular Carcinoma 2026; doi: 10.2147/JHC.S575986
|
| 17 |
Joo Dong Park, Ha Eun Shin, Hye Jung Jang, Seunghyo Ko, Yeon Su An, Jun Seob Lee, Sehoon Moon, Hyungseok Seo, Yewon Kim, Yohan Kim, Jun-Hyeok Han, Chun Gwon Park, Dong-Hyun Kim, Wooram Park. Synergistic immunotherapeutic effects of irreversible electroporation and CAR-NK cell therapy against hepatocellular carcinoma. Signal Transduction and Targeted Therapy 2026; 11(1) doi: 10.1038/s41392-026-02627-2
|
| 18 |
Albert Qin, Chang-Ru Wu, Ming-Chih Ho, Chan-Yen Tsai, Pei-Jer Chen. Sequential Therapy with Ropeginterferon Alfa-2b and Anti-Programmed Cell Death 1 Antibody for Inhibiting the Recurrence of Hepatitis B-Related Hepatocellular Carcinoma: From Animal Modeling to Phase I Clinical Results. International Journal of Molecular Sciences 2023; 25(1) doi: 10.3390/ijms25010433
|
| 19 |
Haitao Jiang, Weibin Hu, Lingling Yuan. Targeting the SCP2/HSPB1 Axis: A Novel Mechanism Underlying Ferroptosis Regulation and Hepatocellular Carcinoma Progression. The Tohoku Journal of Experimental Medicine 2026; 268(3) doi: 10.1620/tjem.2025.J116
|
| 20 |
Youjin Wang, Huiyun Guan, Peibei Duan. Glycyrrhetinic Acid Inhibits Malignant Progression of Hepatocellular Carcinoma by Inducing Autophagy and Regulating Macrophage Polarization via the TGF-β1/SMAD Pathway. Hepatitis Monthly 2026; 26(1) doi: 10.5812/hepatmon-169009
|
| 21 |
Ravi Parhar, Prakash Ramachandran. Sinusoidal Cells in Liver Diseases. 2024; doi: 10.1016/B978-0-323-95262-0.00006-1
|
| 22 |
Haukur Einarsson, Rondell P. Graham. How Do I Diagnose Fibrolamellar Carcinoma?. Modern Pathology 2025; 38(4) doi: 10.1016/j.modpat.2025.100711
|
| 23 |
Early Recurrence of HCC Is Driven by Inflammation-Related HIF-1α Independent Angiogenesis Rather than Hypoxia-Induced Immune Escape. Biomolecules 2026; 16(5) doi: 10.3390/biom16050723
|
| 24 |
Kelly O. Otakhor, Mohd Ali Abbas Zaidi, Rebecca E. Oberley-Deegan, Moorthy P. Ponnusamy, Kurt W. Fisher, Micah B. Schott. Rab5 nucleotide binding promotes oxidative metabolism to fuel hepatocellular carcinoma cell proliferation. Journal of Biological Chemistry 2026; 302(4) doi: 10.1016/j.jbc.2026.111321
|
| 25 |
Shiheng Wu, Xinxing Zhang, Jin Bao, Naiying Sun, Wenjun Guo, Baogui Wang, Xingjie Yang. Hepatocellular carcinoma‑cavernous hemangioma collision tumor: A case report. Oncology Letters 2023; 27(2) doi: 10.3892/ol.2023.14207
|
| 26 |
S. Vancoillie, E. Willems, C. De Meyere, I. Parmentier, C. Verslype, Mathieu D'Hondt. Robotic versus laparoscopic repeat hepatectomy: A comparative single-center study of perioperative outcomes. European Journal of Surgical Oncology 2025; 51(1) doi: 10.1016/j.ejso.2024.109376
|
| 27 |
Yuzhen Huang, Ni Yang, Su Wen, Ziwei Fang, Yucong Zhang, Zonghao Qian, Yi Huang, Tiejun Yin, Cuntai Zhang, Le Zhang. Overexpression of ORAOV1 and its association with immunotherapy resistance in hepatocellular carcinoma. PeerJ 2025; 13 doi: 10.7717/peerj.20390
|
| 28 |
Panagiota Maravelia, Haidong Yao, Curtis Cai, Daniela Nascimento Silva, Jennifer Fransson, Ola B Nilsson, Yong-Chen William Lu, Patrick Micke, Johan Botling, Francesca Gatto, Giulia Rovesti, Mattias Carlsten, Matti Sallberg, Per Stål, Carl Jorns, Marcus Buggert, Anna Pasetto. Unlocking novel T cell-based immunotherapy for hepatocellular carcinoma through neoantigen-driven T cell receptor isolation. Gut 2025; 74(7) doi: 10.1136/gutjnl-2024-334148
|
| 29 |
Thitiporn Pathomjaruwat, Yaowarat Matchim, Jane M. Armer. Health-related quality of life in Thai patients with hepatocellular carcinoma and its influencing factors: A cross-sectional study. Belitung Nursing Journal 2025; 11(4) doi: 10.33546/bnj.3853
|
| 30 |
Junwei Huang, Yiming Tao, Jianguo Yao, Xiaorui Song, Yiming Li, Yiting Yuan. Metabolic syndrome is associated with worse prognosis in elderly patients with hepatocellular carcinoma. Frontiers in Oncology 2025; 15 doi: 10.3389/fonc.2025.1542328
|
| 31 |
Afrasim Moin, Talib Hussain, Ahmed Alafnan, Abdulwahab Alamri, Saeed Alghamdi, Syed Mohd.Danish Rizvi, Sirajudheen Anwar, Muskan Chadha, Mohammad Khalid, Rohit Kumar Tiwari, Afza Ahmad. Synthesis, characterization, antioxidant and anticancer potential of Kalanchoe pinnata green synthesized silver nanoparticles targeting p53/MDM2 nexus in hepatic cancer: integrated in vitro and in silico study. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-40542-2
|